Study identifies immune cells that promote growth of beta cells in type 1 diabetes

September 27, 2013

Joslin researchers have identified immune cells that promote growth of beta cells in type 1 diabetes. This study provides further evidence of a changed role for immune cells in type 1 diabetes pathology. The study appears online today and will also appear in the January issue of Diabetes.

In type 1 diabetes, the infiltrates pancreatic islets and destroys -producing beta cells. However, previous studies in non-obese diabetic (NOD) mice have suggested that immune cells can also contribute to preserving beta cells. This notion is strengthened by the observation by Joslin researchers who reported that members of the Center's 50-Year Medalist Study, who have lived with type 1 diabetes for 50 years or more, retain some beta cells and produce insulin.

"The traditional view of type 1 diabetes was that immune cells killed all beta cells and people with the disease would have to take insulin for life. But we know that some beta cells do survive and secrete insulin even when the patients have had type 1 diabetes for 50 years," says senior author Rohit N. Kulkarni, M.D., Ph.D., a Senior Investigator in the Section on Islet Cell and Regenerative Biology at Joslin and Associate Professor of Medicine at Harvard Medical School.

In this study, Joslin researchers were interested in learning exactly how immune cells could promote beta cell growth and identifying the type of cell and the mechanisms underlying this effect.

In a series of experiments, the researchers injected NOD mice with immune cells from the of donor NOD mice and assessed their effects on beta cells. The immune cells tested included subtypes of B or T immune cells.

The researchers found that it is T cells not B cells that are associated with beta . Mice that received B cells showed no difference in beta cell growth. Mice that received the T cell subtypes CD4+ and CD8+ showed an elevation in all markers of beta cell proliferation compared to mice that did not receive them. The researchers also found that beta cell growth happens after islets are infiltrated by immune cells and is independent of the effects of glucose and insulin.

Further experiments with cell cultures showed that CD4+ and CD8+ cells secrete inflammatory cytokines and chemokines (Interleukin 2, Interleukin 6, Interleukin 10, MIP-1? and RANTES), which together enhanced beta cell proliferation. This is the first study to report that this group of "soluble factors" is involved in promoting beta cell growth.

"This gives us new insights into what is happening in the pathology of type 1 diabetes. The immune cells we identified send signals which appear to protect and promote growth of . This opens up an exciting new area that scientists have thought about; now we have the hard data to substantiate it," says Dr. Kulkarni.

The next step is to investigate the effects of on human beta cell growth. The factors secreted from CD4+ and CD8+ cells are potential therapeutic candidates to enhance beta cell growth to prevent or delay the onset of .

"We need to learn more about the relationship of beta cell death and proliferation to determine if we can harness these soluble substances to encourage beta cell proliferation rather than destruction," says Dr. Kulkarni.

Related Stories

The role of beta cell regeneration in type 2 diabetes

October 10, 2012

The World Health Organization (WHO) has declared type 2 diabetes as the epidemic of the 21st century. A study is focusing on understanding the mechanisms underlying insulin resistance and the role of beta-cell regeneration.

Fractalkine: New protein target for controlling diabetes

April 11, 2013

Researchers at the University of California, San Diego School of Medicine have identified a previously unknown biological mechanism involved in the regulation of pancreatic islet beta cells, whose role is to produce and release ...

No rebirth for insulin secreting pancreatic beta cells

April 24, 2013

Pancreatic beta cells store and release insulin, the hormone responsible for stimulating cells to convert glucose to energy. The number of beta cells in the pancreas increases in response to greater demand for insulin or ...

Adult stem cells could hold key to curing Type 1 diabetes

May 29, 2013

Millions of people with type 1 diabetes depend on daily insulin injections to survive. They would die without the shots because their immune system attacks the very insulin-producing cells it was designed to protect. Now, ...

Major hurdle cleared to diabetes transplants

June 13, 2013

(Medical Xpress)—Researchers at Washington University School of Medicine in St. Louis have identified a way to trigger reproduction in the laboratory of clusters of human cells that make insulin, potentially removing a ...

Recommended for you

Promising progress for new treatment of type 1 diabetes

July 30, 2015

New research from Uppsala University shows promising progress in the use of anti-inflammatory cytokine for treatment of type 1 diabetes. The study, published in the open access journal Scientific Reports, reveals that administration ...

Bacteria may cause type 2 diabetes

June 1, 2015

Bacteria and viruses have an obvious role in causing infectious diseases, but microbes have also been identified as the surprising cause of other illnesses, including cervical cancer (Human papilloma virus) and stomach ulcers ...

'Crosstalk' gives clues to diabetes

June 15, 2015

Sometimes, listening in on a conversation can tell you a lot. For Mark Huising, an assistant professor in the Department of Neurobiology, Physiology and Behavior at the UC Davis College of Biological Sciences, that crosstalk ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.